Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling.
Journal: Translational oncology
Published: November 12, 2025
Dihydroartemisinin Promotes N1 Polarization of Tumor-Associated Neutrophils and Enhances Their Anti-Tumor Activity via Hub Gene Modulation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 07, 2025
Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy.
Journal: Angewandte Chemie (International ed. in English)
Published: September 25, 2025
SLC38A4 promotes Kupffer cell phagocytosis and suppresses tumor liver metastasis.
Journal: Experimental & molecular medicine
Published: September 09, 2025
Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study.
Journal: Frontiers in oncology
Published: July 10, 2025
Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies.
Journal: Frontiers in immunology
Published: January 12, 2025
Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing.
Journal: Signal transduction and targeted therapy
Published: September 08, 2024
ERCC3-Related Genes May Aid in the Prognostic and Immunotherapeutic Analysis of Hepatocellular Carcinoma.
Journal: Combinatorial chemistry & high throughput screening
Published: December 12, 2023
Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8+ T cells.
Journal: Clinical and translational medicine
Published: April 14, 2023
Last Updated: 09/26/2026